SQZ BIOTECHNOLOGIES CO

Profile

Company Names

SQZ BIOTECHNOLOGIES CO

Addresses

200 ARSENAL YARDS BLVD., STE. 210, WATERTOWN, MA 02472

134 COOLIDGE AVE., WATERTOWN, MA 02472

134 COOLIDGE AVENUE, WATERTOWN, MA 02472

100 MORRISSEY BLVD, VENTURE DEVELOPMENT CENTER, BOSTON, MA 02125

333 HIGHLAND AVE., SOMERVILLE, MA 02144

Phone Numbers

617-898-8824
6177588672
6178988824

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$166,664,080.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2019-12-19 
$66,253,006.00 
$70,203,000.00 
$3,949,994.00 
Equity 
4
2018-05-11 
$71,253,215.00 
INDEFINITE 
INDEFINITE 
Equity 
3
2016-09-19 
$24,061,840.00 
$24,061,840.00 
$0.00 
Equity 
2
2015-06-15 
$5,081,019.00 
$5,081,019.00 
$0.00 
Equity 
1
2014-03-24 
$15,000.00 
$1,000,000.00 
$985,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ZAFRIRA 
 
AVNUR 
DIRECTOR
ALEX 
 
BALCOM 
EXECUTIVE OFFICER
ALEXANDRA 
 
BALCOM 
EXECUTIVE OFFICER
HOWARD 
 
BERNSTEIN 
EXECUTIVE OFFICER
HOWARD 
 
BERNSTEIN, M.D., PH.D. 
EXECUTIVE OFFICER
KRIS 
 
ELVERUM 
EXECUTIVE OFFICER
DAVID 
 
FIRST 
EXECUTIVE OFFICER
PUSHKAL 
 
GARG 
DIRECTOR
KLAVS 
 
JENSEN 
EXECUTIVE OFFICER, DIRECTOR
KLAVS 
F. 
JENSEN, PH.D. 
DIRECTOR
LAWRENCE 
 
KNOPF 
EXECUTIVE OFFICER
ROBERT 
 
LANGER 
DIRECTOR
MICROCHIPS, INC.   |  ARSENAL MEDICAL, INC.   |  ALSERES PHARMACEUTICALS INC /DE   |  ECHO THERAPEUTICS, INC.   |  MICELL TECHNOLOGIES INC   |  CERULEAN PHARMA INC.   |  HUMACYTE INC   |  COMBINENT BIOMEDICAL SYSTEMS, INC.   |  TARIS BIOMEDICAL INC   |  KALA PHARMACEUTICALS, INC.   |  FIBROCELL SCIENCE, INC.   |  PREDICTIVE BIOSCIENCES, INC   |  SEVENTH SENSE BIOSYSTEMS, INC.   |  T2 BIOSYSTEMS, INC.   |  SEMPRUS BIOSCIENCES CORP   |  LIQUIDX, INC.   |  ARSENAL VASCULAR, INC.   |  ARSENAL MEDICAL, INC.   |  SELECTA BIOSCIENCES INC   |  STEMNION, INC.   |  480 BIOMEDICAL, INC.   |  LIVING PROOF INC   |  DX BIOSCIENCES, INC.   |  MODERNA LLC   |  HUMACYTE, INC   |  XTUIT PHARMACEUTICALS, INC.   |  SQZ BIOTECHNOLOGIES CO   |  NOVEOME BIOTHERAPEUTICS, INC.   |  LYNDRA, INC.   |  MODERNA THERAPEUTICS, INC.   |  VERSEAU THERAPEUTICS, INC.   |  FREQUENCY THERAPEUTICS, INC.   |  SUONO BIO, INC.   |  COMBINED THERAPEUTICS, INC.   |  HUMACYTE, INC.   |  SEER BIOSCIENCES, INC.   |  LANDSDOWNE LABS, LLC   |  LIKEMINDS, INC./DE   |  TARVEDA THERAPEUTICS, INC.   |  LUMINOPIA, INC.   |  LYRA THERAPEUTICS, INC.   |  ABPRO CORP   |  GLYMPSE BIO, INC.   |  EPIBONE, INC.   |  TEAL BIO, INC.   |  ZWI THERAPEUTICS, INC.   |  LYNDRA THERAPEUTICS, INC.   |  KENDALL CAPITAL PARTNERS I, L.P.   |  BILAYER THERAPEUTICS, INC.   |  XENTER, INC.   |  VIVTEX CORP   |  SYNTIS BIO, INC.   |  OMNIPULSE BIOSCIENCES, INC.
ROBERT 
 
LANGER, PH.D. 
DIRECTOR
ROBERT 
 
LANGER, SC.D. 
DIRECTOR
ROBERT 
S. 
LANGER, SC.D. 
DIRECTOR
AGUSTIN 
 
LOPEZ-MARQUEZ 
EXECUTIVE OFFICER
TERI 
 
LOXAM 
EXECUTIVE OFFICER
MARK 
 
MURCKO, PH.D. 
DIRECTOR
GARRY 
A. 
NICHOLSON 
DIRECTOR
OLIVER 
 
ROSEN, M.D. 
EXECUTIVE OFFICER
AMY 
W. 
SCHULMAN 
EXECUTIVE OFFICER, DIRECTOR
ARMON 
 
SHAREI 
EXECUTIVE OFFICER, DIRECTOR
ARMON 
 
SHAREI, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-12-19 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-11 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-19 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-19 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-03-24 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#